drugs

As the 2020 election creeps closer, candidates are focusing increasingly more on solving one of the most vexing problems Americans regularly encounter: the incredibly high cost of prescription drugs.

According to a new analysis released last month, Americans spent $3.65 trillion dollars on health care in 2018 – more than the entire gross domestic product of Canada.

The future of Obamacare is as tenuous as ever thanks to the Trump administration’s restoration of federalism.

At last, regulatory flexibility for the seriously ill from the FDA.

A “right to healthcare” is a seductive idea that many Americans accept without thinking. But we need to take a closer look at what this means.

The other day a reporter asked me to explain why the government cannot negotiate the price of Medicare drugs lower than private drug plans run by pharmacy benefit managers (PBMs).

Too many politicians are willing to fleece taxpayers for political gain.

Before 1990, American physicians who had completed 3 years or more of rigorous training in a specialty and passed an examination were awarded lifetime “board certification.”

The opioid crisis in America is real, it is lethal, and it may be killing the nice family that lives next door to you.

Almost everyone involved in health care will tell you that the greatest problem in our system is that we pay on a fee-for-service basis. Almost everyone is wrong.

Charlie Katebi – a fellow in health care reform at the Millennial Policy Center at the Liberty Group in Denver – spoke on the topic of “A Health Care Agenda for Millennials.”

On May 26, Maryland became the first state to pass a law which applies specifically to “price gouging” practices by generic pharmaceutical manufacturers of essential drugs.

The reported success of the Affordable Care Act (ACA or ObamaCare) is based on enrollment numbers. Millions more have “coverage.”